Literature DB >> 24100448

Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects.

Jacqueline Stockley1, Neil V Morgan, Danai Bem, Gillian C Lowe, Marie Lordkipanidzé, Ban Dawood, Michael A Simpson, Kirsty Macfarlane, Kevin Horner, Vincenzo C Leo, Katherine Talks, Jayashree Motwani, Jonathan T Wilde, Peter W Collins, Michael Makris, Steve P Watson, Martina E Daly.   

Abstract

We analyzed candidate platelet function disorder genes in 13 index cases with a history of excessive bleeding in association with a significant reduction in dense granule secretion and impaired aggregation to a panel of platelet agonists. Five of the index cases also had mild thrombocytopenia. Heterozygous alterations in FLI1 and RUNX1, encoding Friend leukemia integration 1 and RUNT-related transcription factor 1, respectively, which have a fundamental role in megakaryocytopoeisis, were identified in 6 patients, 4 of whom had mild thrombocytopenia. Two FLI1 alterations predicting p.Arg337Trp and p.Tyr343Cys substitutions in the FLI1 DNA-binding domain abolished transcriptional activity of FLI1. A 4-bp deletion in FLI1, and 2 splicing alterations and a nonsense variation in RUNX1, which were predicted to cause haploinsufficiency of either FLI1 or RUNX1, were also identified. Our findings suggest that alterations in FLI1 and RUNX1 may be common in patients with platelet dense granule secretion defects and mild thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24100448      PMCID: PMC3862284          DOI: 10.1182/blood-2013-06-506873

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Regulation of the megakaryocytic glycoprotein IX promoter by the oncogenic Ets transcription factor Fli-1.

Authors:  L S Bastian; B A Kwiatkowski; J Breininger; S Danner; G Roth
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

Review 2.  Inherited platelet disorders.

Authors:  A T Nurden; K Freson; U Seligsohn
Journal:  Haemophilia       Date:  2012-07       Impact factor: 4.287

3.  RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidization.

Authors:  Larissa Lordier; Dominique Bluteau; Abdelali Jalil; Céline Legrand; Jiajia Pan; Philippe Rameau; Dima Jouni; Olivier Bluteau; Thomas Mercher; Catherine Leon; Christian Gachet; Najet Debili; William Vainchenker; Hana Raslova; Yunhua Chang
Journal:  Nat Commun       Date:  2012-03-06       Impact factor: 14.919

4.  Characterization of human glycoprotein VI gene 5' regulatory and promoter regions.

Authors:  Kenichi Furihata; Thomas J Kunicki
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

5.  Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant-negative, or hypomorphic alleles.

Authors:  Christina J Matheny; Maren E Speck; Patrick R Cushing; Yunpeng Zhou; Takeshi Corpora; Michael Regan; Miki Newman; Liya Roudaia; Caroline L Speck; Ting-Lei Gu; Stephen M Griffey; John H Bushweller; Nancy A Speck
Journal:  EMBO J       Date:  2007-02-08       Impact factor: 11.598

6.  Paris-Trousseau syndrome : clinical, hematological, molecular data of ten new cases.

Authors:  Remi Favier; Katayoun Jondeau; Patrice Boutard; Paul Grossfeld; Philippe Reinert; Christopher Jones; Francesco Bertoni; Elisabeth M Cramer
Journal:  Thromb Haemost       Date:  2003-11       Impact factor: 5.249

7.  FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia.

Authors:  Hana Raslova; Emiko Komura; Jean Pierre Le Couédic; Frederic Larbret; Najet Debili; Jean Feunteun; Olivier Danos; Olivier Albagli; William Vainchenker; Rémi Favier
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

8.  The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors.

Authors:  D K Watson; F E Smyth; D M Thompson; J Q Cheng; J R Testa; T S Papas; A Seth
Journal:  Cell Growth Differ       Date:  1992-10

9.  Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators.

Authors:  Marloes R Tijssen; Ana Cvejic; Anagha Joshi; Rebecca L Hannah; Rita Ferreira; Ariel Forrai; Dana C Bellissimo; S Helen Oram; Peter A Smethurst; Nicola K Wilson; Xiaonan Wang; Katrin Ottersbach; Derek L Stemple; Anthony R Green; Willem H Ouwehand; Berthold Göttgens
Journal:  Dev Cell       Date:  2011-05-17       Impact factor: 12.270

10.  Recessive mutations in EPG5 cause Vici syndrome, a multisystem disorder with defective autophagy.

Authors:  Thomas Cullup; Ay Lin Kho; Carlo Dionisi-Vici; Birgit Brandmeier; Frances Smith; Zoe Urry; Michael A Simpson; Shu Yau; Enrico Bertini; Verity McClelland; Mohammed Al-Owain; Stefan Koelker; Christian Koerner; Georg F Hoffmann; Frits A Wijburg; Amber E ten Hoedt; R Curtis Rogers; David Manchester; Rie Miyata; Masaharu Hayashi; Elizabeth Said; Doriette Soler; Peter M Kroisel; Christian Windpassinger; Francis M Filloux; Salwa Al-Kaabi; Jozef Hertecant; Miguel Del Campo; Stefan Buk; Istvan Bodi; Hans-Hilmar Goebel; Caroline A Sewry; Stephen Abbs; Shehla Mohammed; Dragana Josifova; Mathias Gautel; Heinz Jungbluth
Journal:  Nat Genet       Date:  2012-12-09       Impact factor: 38.330

View more
  30 in total

1.  Singling out FLI1 in Paris-Trousseau syndrome.

Authors:  Hervé Falet
Journal:  Blood       Date:  2017-06-29       Impact factor: 22.113

Review 2.  Role of RUNX1 in hematological malignancies.

Authors:  Raman Sood; Yasuhiko Kamikubo; Paul Liu
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

Review 3.  New Insights Into the Differentiation of Megakaryocytes From Hematopoietic Progenitors.

Authors:  Leila J Noetzli; Shauna L French; Kellie R Machlus
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-05-02       Impact factor: 8.311

Review 4.  Linkage between the mechanisms of thrombocytopenia and thrombopoiesis.

Authors:  Koji Eto; Shinji Kunishima
Journal:  Blood       Date:  2016-01-19       Impact factor: 22.113

Review 5.  Hematopoietic transcription factor mutations: important players in inherited platelet defects.

Authors:  Natthapol Songdej; A Koneti Rao
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

6.  FLI1 level during megakaryopoiesis affects thrombopoiesis and platelet biology.

Authors:  Karen K Vo; Danuta J Jarocha; Randolph B Lyde; Vincent Hayes; Christopher S Thom; Spencer K Sullivan; Deborah L French; Mortimer Poncz
Journal:  Blood       Date:  2017-04-21       Impact factor: 22.113

Review 7.  Inherited platelet dysfunction and hematopoietic transcription factor mutations.

Authors:  Natthapol Songdej; A Koneti Rao
Journal:  Platelets       Date:  2016-07-27       Impact factor: 3.862

Review 8.  Induced Pluripotent Stem Cell-Derived Megakaryocytes and Platelets for Disease Modeling and Future Clinical Applications.

Authors:  Sara Borst; Xiuli Sim; Mortimer Poncz; Deborah L French; Paul Gadue
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-10-05       Impact factor: 8.311

9.  ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants.

Authors:  Xi Luo; Simone Feurstein; Shruthi Mohan; Christopher C Porter; Sarah A Jackson; Sioban Keel; Michael Chicka; Anna L Brown; Chimene Kesserwan; Anupriya Agarwal; Minjie Luo; Zejuan Li; Justyne E Ross; Panagiotis Baliakas; Daniel Pineda-Alvarez; Courtney D DiNardo; Alison A Bertuch; Nikita Mehta; Tom Vulliamy; Ying Wang; Kim E Nichols; Luca Malcovati; Michael F Walsh; Lesley H Rawlings; Shannon K McWeeney; Jean Soulier; Anna Raimbault; Mark J Routbort; Liying Zhang; Gabriella Ryan; Nancy A Speck; Sharon E Plon; David Wu; Lucy A Godley
Journal:  Blood Adv       Date:  2019-10-22

10.  RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML.

Authors:  Anna L Brown; Peer Arts; Catherine L Carmichael; Milena Babic; Julia Dobbins; Chan-Eng Chong; Andreas W Schreiber; Jinghua Feng; Kerry Phillips; Paul P S Wang; Thuong Ha; Claire C Homan; Sarah L King-Smith; Lesley Rawlings; Cassandra Vakulin; Andrew Dubowsky; Jessica Burdett; Sarah Moore; Grace McKavanagh; Denae Henry; Amanda Wells; Belinda Mercorella; Mario Nicola; Jeffrey Suttle; Ella Wilkins; Xiao-Chun Li; Joelle Michaud; Peter Brautigan; Ping Cannon; Meryl Altree; Louise Jaensch; Miriam Fine; Carolyn Butcher; Richard J D'Andrea; Ian D Lewis; Devendra K Hiwase; Elli Papaemmanuil; Marshall S Horwitz; Georges Natsoulis; Hugh Y Rienhoff; Nigel Patton; Sally Mapp; Rachel Susman; Susan Morgan; Julian Cooney; Mark Currie; Uday Popat; Tilmann Bochtler; Shai Izraeli; Kenneth Bradstock; Lucy A Godley; Alwin Krämer; Stefan Fröhling; Andrew H Wei; Cecily Forsyth; Helen Mar Fan; Nicola K Poplawski; Christopher N Hahn; Hamish S Scott
Journal:  Blood Adv       Date:  2020-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.